Food as Medicine Market is estimated to be US$ 36.6 Billion by 2034 with a CAGR of 4.3% during the forecast period

Download Sample

Published Date: January 2025

Food as Medicine Market was valued at US$ 25 Billion in 2024 and is projected to grow at a CAGR of 4.3% to reach US$ 36.6 Billion by 2034.

Consumers are choosing to maximize their calorie intake, owing in part to growing food fortification technologies and discoveries of nutrient benefits. As a result, the global expansion of functional foods is expected to outstrip that of traditional foods in both developed and emerging countries. According to NMI research, the primary motivations for using functional and fortified foods are to improve general health and enhance nutrient consumption—almost like a nutritional insurance policy. In fact, three-quarters of Americans believe that eating healthy meals and drinking healthy beverages can improve their quality of life. Furthermore, more than a quarter of Americans feel that certain medicines can be replaced with functional foods and beverages. It's not surprise, then, that the majority of customers would use food and beverages to prevent and treat a variety of health problems, such as heart disease, high blood pressure, fatigue, bowel irregularity, and even cancer.

Key Highlights:

In 2021, With the launch of Elix, a nutraceutical drink made with whole cacao fruit that aims to promote circulatory health by helping people maintain the elasticity of their blood vessels, Barry Callebaut, one of the world's largest chocolate and cocoa product manufacturers and suppliers, has officially entered the functional beverages market.
In February 2020, Fresenius Kabi AG announced a partnership with Vifor Pharma to build a joint venture in China. The goal of this enterprise is to provide iron deficiency treatment to people in China. This will help the brand gain visibility in the Chinese market.

Analyst View:

The rising frequency of diseases such as malnutrition and diabetes is also a major driver of market expansion. According to the International Diabetes Federation (IDF), around 463 million persons had diabetes in 2019, with this number expected to rise to 700 million by 2045. Medical foods can help alleviate the symptoms of diabetic neuropathy, which is one of the most common complications in diabetic patients. Furthermore, according to WHO report from 2020, roughly 462 million adults worldwide are underweight, making medicinal meals, along with enteral feeding, and the first line of treatment for malnourished patients. Medical foods that can help with these deficiencies creates growth opportunities for the Food as medicine market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Food As Medicine Market, By Route of Administration (Oral and Enteral), By Product (Pills, Powder and Others), Application (Chronic Kidney Diseases, Minimal Hepatic Encephalopathy, Chemotherapy-Induced Diarrhea, Pathogen Related Infections and Others), By Distribution Channel (Online Sales, Institutional Sales and Retail Sales) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2034”

Key Market Insights from the report:

Food as Medicine Market was valued at US$ 25 Billion in 2024 and is projected to grow at a CAGR of 4.3% to reach US$ 36.6 Billion by 2034. The Food as Medicine Market is segmented based on route of administration, product, application, distribution channel and region.

By Route of Administration, the Food as Medicine Market is segmented into oral and enteral.
By Products, the Food as Medicine Market is segmented into Pills, Powder and Others.
By Application, the Food as Medicine Market is segmented into Chronic Kidney Diseases, Minimal Hepatic Diseases, Chemotherapy-Induced Diarrhea, Pathogen Related Infections and Others.
By Distribution Channel, the Food as Medicine Market is segmented into Online Sales, Institutional Sales and Offline Sales.
By region, the Food as Medicine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the food as medicine market in terms of revenue.

Competitive Landscape:

Some of the key industry leaders in the global food as medicine market are Danone, Nestle Nutrition, Abbott Nutrition, Targeted Medical Pharma, Inc., Primus Pharmaceuticals, Inc., Mead Johnson & Company, LLC., Medtrition, Inc. and Fresenius Kabi AG. Due to the surge in demand for medicinal foods combined with technical developments, competition among existing providers is fierce. Furthermore, the market is consolidated, with the main firms controlling the majority of the market.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered